Aclaris Therapeutics (ACRS) Capital Expenditures (2014 - 2026)
Aclaris Therapeutics (ACRS) recorded Capital Expenditures of $58,000 in Q2 2026, up 176.2% from $21,000 a year earlier and up 346.2% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Capital Expenditures (2014 - 2026) Analysis & Trends
On a TTM basis, Aclaris Therapeutics' Capital Expenditures came in at $118,000 as of Jun 30, 2026, up 84.4% year-over-year; for FY2025, it was $111,000, down 8.3% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of -24.5% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $121,000 in FY2024 (-90.8%), $1.31 million in FY2023 (+116.4%), $605,000 in FY2022 (+96.4%) and $308,000 in FY2021 (-32.0%).
- The Q2 2026 figure is the highest quarterly Capital Expenditures since Q1 2024.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 320.0% in Q4 2023, against a decline of 81.6% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $13,000 (Q1 2026), $24,000 (Q4 2025) and $23,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Aclaris Therapeutics | 738.27 Mn | 738.27 Mn | 1.41 Mn | 58,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58,000.00 |
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Jun 30, 2024 | -14,000.00 |
| Mar 31, 2024 | 135,000.00 |
| Dec 31, 2023 | 441,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Jun 30, 2023 | 231,000.00 |
| Mar 31, 2023 | 553,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 186,000.00 |
| Mar 31, 2022 | 164,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Dec 31, 2020 | 8,000.00 |
| Sep 30, 2020 | 304,000.00 |
API Access
Aclaris Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();